Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_assertion description "[However, RUNX2 expression was significantly decreased in patients with elevated PSA levels (?20?ng?ml(-1)), a Gleason score ?8 and metastatic disease compared to those with low PSA, low Gleason score and non-metastatic disease (P=0.023, 0.005 and 0.014, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_assertion evidence source_evidence_literature NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_assertion SIO_000772 22890388 NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_assertion wasDerivedFrom befree-2016 NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_assertion wasGeneratedBy ECO_0000203 NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.
- befree-2016 importedOn "2016-02-19" NP1004923.RA4yLndxW7_Lw6cT-3i22A-THHfXOpZLp1_Av_Iki97yY130_provenance.